Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice The current randomized trials ...
The complete findings of the RCT-DUPLICATE demonstration project are published today in JAMA. This three-year initiative tested whether researchers asking clinical questions in real-world data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results